4.5 Review

The 5-HT1F receptor agonist lasmiditan as a potential treatment of migraine attacks: a review of two placebo-controlled phase II trials

Related references

Note: Only part of the references are listed.
Article Clinical Neurology

Evidence for a Vascular Factor in Migraine

Mohammad S. Asghar et al.

ANNALS OF NEUROLOGY (2011)

Article Clinical Neurology

Origin of pain in migraine: evidence for peripheral sensitisation

Jes Olesen et al.

LANCET NEUROLOGY (2009)

Review Neurosciences

NEUROBIOLOGY OF MIGRAINE

P. J. Goadsby et al.

NEUROSCIENCE (2009)

Article Multidisciplinary Sciences

Disruption of communication between peripheral and central trigeminovascular neurons mediates the antimigraine action of 5HT1B/1D receptor agonists

D Levy et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)

Article Medicine, General & Internal

Calcitonin gene-related peptide receptor antagonist BIBN4096BS for the acute treatment of migraine

J Olesen et al.

NEW ENGLAND JOURNAL OF MEDICINE (2004)

Article Clinical Neurology

What do patients with migraine want from acute migraine treatment?

RB Lipton et al.

HEADACHE (2002)